ACT in action.

Hear about new features at our upcoming Growing Hope fundraiser event, clinical trial updates from ACT research partners and more.

Learn more about ACT’s virtual research update in May, as well as other upcoming events in ACT’s April newsletter.

Through your support, Achieving Cures Together has made a lasting impact in patient lives and medical care. With the University of Minnesota Microbiota Therapeutics Program, we have treated over 2,000 patients with recurrent C. difficile Infections and provided over 4,500 microbiota transplant treatments to patients in clinical trials. And our academic partnerships and research indications connected with microbial health continue to expand.

In ACT’s August newsletter, hear directly from our research partners in ACT’s 2023 research update and learn about our upcoming events this fall.

What do Multiple Sclerosis, Diverticulitis and Multi-Drug Antibiotic Resistance have in common? ACT is funding the microbiota therapy being used in new clinical trials to target these separate conditions. Read more about our growing network of research collaborations and other updates in our current newsletter.

Hear from ACT’s research partners around the country in our December 2022 newsletter!